• Epithelial-mesenchymal transition in non small-cell lung cancer 

      Tsoukalas N., Aravantinou-Fatorou E., Tolia M., Giaginis C., Galanopoulos M., Kiakou M., Kostakis I.D., Dana E., Vamvakaris I., Korogiannos A., Tsiambas E., Salemis N., Kyrgias G., Karameris A., Theocharis S. (2017)
      Background/Aim: Lung cancer is the first cause of cancer related deaths in both males and females. Epithelial-mesenchymal transition (EMT) is a reversible process by which epithelial cells transform to mesenchymal stem ...
    • Expression of Fibroblast Activation Protein Is Enriched in Neuroendocrine Prostate Cancer and Predicts Worse Survival 

      Vlachostergios P.J., Karathanasis A., Tzortzis V. (2022)
      Background: Advanced prostate cancer (PC) may accumulate genomic alterations that hallmark lineage plasticity and transdifferentiation to a neuroendocrine (NE) phenotype. Fibroblast activation protein (FAP) is a key player ...
    • Gastrointestinal stromal tumors (GISTs) and synchronous intra-abdominal malignancies: Case series of a single institution’s experience 

      Diamantis A., Samara A.A., Symeonidis D., Baloyiannis I., Vasdeki D., Tolia M., Volakakis G., Mavrovounis G., Tepetes K. (2021)
      Background: Gastrointestinal stromal tumors (GISTs) quite often co-exist with other primary tumors, as seen in up to 33% of cases. In the literature such occurrences have primarily been described through case reports and ...
    • HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemia 

      de Barrios O., Galaras A., Trincado J.L., Azagra A., Collazo O., Meler A., Agraz-Doblas A., Bueno C., Ballerini P., Cazzaniga G., Stam R.W., Varela I., De Lorenzo P., Valsecchi M.G., Hatzis P., Menéndez P., Parra M. (2021)
      [No abstract available]
    • HOTAIR as a prognostic predictor for diverse human cancers: A meta- and bioinformatics analysis 

      Toy H.I., Okmen D., Kontou P.I., Georgakilas A.G., Pavlopoulou A. (2019)
      Several studies suggest that upregulated expression of the long non-coding RNA HOX transcript antisense RNA (HOTAIR) is a negative predictive biomarker for numerous cancers. Herein, we performed a meta-analysis to further ...
    • HPV infection in oropharyngeal squamous cell carcinomas: Correlation with tumor size 

      Gletsou E., Papadas T.A., Baliou E., Tsiambas E., Ragos V., Armata I.E., Metaxas G.E., Fotiades P.P. (2018)
      Purpose: Human papillomavirus (HPV) is implicated in carcinogenesis of a variety of epithelia, including oropharyngeal and laryngeal. High risk (HR) HPV persistent infection in head and neck squamous cell carcinomas (HNSCC) ...
    • Immune-based treatment re-challenge in renal cell carcinoma: A systematic review and meta-analysis 

      Papathanassiou M., Tamposis I., Exarchou-Kouveli K.K., Kontou P.I., de Paz A.T., Mitrakas L., Samara M., Bagos P.G., Tzortzis V., Vlachostergios P.J. (2022)
      Introduction: The use of immune checkpoint inhibitors (ICIs) as a front-line treatment for metastatic renal cell carcinoma (RCC) has significantly improved patient’ outcome. However, little is known about the efficacy or ...
    • Immunotherapy Efficacy in the Initial Lines of Treatment in Advanced Upper Gastrointestinal Malignancies: A Systematic Review of the Literature 

      Kamposioras K., Ntellas P., Nikolaou M., Germetaki T., Gazouli I., Dadouli K., Zarkavelis G., Amylidi A.-L., Tolia M., Mauri D. (2021)
      Background: The therapeutic role of immune checkpoint inhibitors (ICIs) has represented the cutting edge of clinical research in upper gastrointestinal (GI) malignancies, with these agents now included in the armamentarium ...
    • In silico methods for the identification of diagnostic and favorable prognostic markers in acute myeloid leukemia 

      Yılmaz H., Toy H.I., Marquardt S., Karakülah G., Küçük C., Kontou P.I., Logotheti S., Pavlopoulou A. (2021)
      Acute myeloid leukemia (AML), the most common type of acute leukemia in adults, is mainly asymptomatic at early stages and progresses/recurs rapidly and frequently. These attributes necessitate the identification of ...
    • Intraoperative radiation therapy (IORT) in head and neck cancer: A systematic review 

      Kyrgias G., Hajiioannou J., Tolia M., Kouloulias V., Lachanas V., Skoulakis C., Skarlatos I., Rapidis A., Bizakis I. (2016)
      Background: Multimodality therapy constitutes the standard treatment of advanced and recurrent head and neck cancer. Since locoregional recurrence comprises a major obstacle in attaining cure, the role of intraoperative ...
    • Investigating Molecular Determinants of Cancer Cell Resistance to Ionizing Radiation Through an Integrative Bioinformatics Approach 

      Toy H.I., Karakülah G., Kontou P.I., Alotaibi H., Georgakilas A.G., Pavlopoulou A. (2021)
      Eradication of cancer cells through exposure to high doses of ionizing radiation (IR) is a widely used therapeutic strategy in the clinical setting. However, in many cases, cancer cells can develop remarkable resistance ...
    • Is locally advanced head-neck cancer one more candidate for accelerated hypofractionation? 

      KOUKOURAKIS I.M., ZYGOGIANNI A., KOULOULIAS V., KYRGIAS G., PANTELIADOU M., NANOS C., ABATZOGLOU I., KOUKOURAKIS M.I. (2021)
      Background/Aim: Hypofractionated accelerated radiotherapy (HypoAR) is widely applied for the treatment of early laryngeal cancer. Its role in locally advanced head-neck cancer (LA-HNC) is unexplored. Patients and Methods: ...
    • Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece 

      Tzouvelekis A., Karampitsakos T., Gomatou G., Bouros E., Tzilas V., Manali E., Tomos I., Trachalaki A., Kolilekas L., Korbila I., Tomos P., Chrysikos S., Gaga M., Daniil Z., Bardaka F., Papanikolaou I.C., Euthymiou C., Papakosta D., Steiropoulos P., Ntolios P., Tringidou R., Papiris S., Antoniou K., Bouros D. (2020)
      Background: Abundant evidence supports an association between Idiopathic Pulmonary Fibrosis (IPF) and lung cancer development. Data on diagnosis and management of patients with IPF and lung cancer are still scarce. Patients ...
    • Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016 

      Fullman N., Yearwood J., Abay S.M., Abbafati C., Abd-Allah F., Abdela J., Abdelalim A., Abebe Z., Abebo T.A., Aboyans V., Abraha H.N., Abreu D.M.X., Abu-Raddad L.J., Adane A.A., Adedoyin R.A., Adetokunboh O., Adhikari T.B., Afarideh M., Afshin A., Agarwal G., Agius D., Agrawal A., Agrawal S., Ahmad Kiadaliri A., Aichour M.T.E., Akibu M., Akinyemi R.O., Akinyemiju T.F., Akseer N., Al Lami F.H., Alahdab F., Al-Aly Z., Alam K., Alam T., Alasfoor D., Albittar M.I., Alene K.A., Al-Eyadhy A., Ali S.D., Alijanzadeh M., Aljunid S.M., Alkerwi A., Alla F., Allebeck P., Allen C., Alomari M.A., Al-Raddadi R., Alsharif U., Altirkawi K.A., Alvis-Guzman N., Amare A.T., Amenu K., Ammar W., Amoako Y.A., Anber N., Andrei C.L., Androudi S., Antonio C.A.T., Araújo V.E.M., Aremu O., Ärnlöv J., Artaman A., Aryal K.K., Asayesh H., Asfaw E.T., Asgedom S.W., Asghar R.J., Ashebir M.M., Asseffa N.A., Atey T.M., Atre S.R., Atteraya M.S., Avila-Burgos L., Avokpaho E.F.G.A., Awasthi A., Ayala Quintanilla B.P., Ayalew A.A., Ayele H.T., Ayer R., Ayuk T.B., Azzopardi P., Azzopardi-Muscat N., Babalola T.K., Badali H., Badawi A., Banach M., Banerjee A., Banstola A., Barber R.M., Barboza M.A., Barker-Collo S.L., Bärnighausen T., Barquera S., Barrero L.H., Bassat Q., Basu S., Baune B.T., Bazargan-Hejazi S., Bedi N., Beghi E., Behzadifar M., Behzadifar M., Bekele B.B., Belachew A.B., Belay S.A., Belay Y.A., Bell M.L., Bello A.K., Bennett D.A., Bennett J.R., Bensenor I.M., Berhe D.F., Bernabé E., Bernstein R.S., Beuran M., Bhalla A., Bhatt P., Bhaumik S., Bhutta Z.A., Biadgo B., Bijani A., Bikbov B., Birungi C., Biryukov S., Bizuneh H., Bolliger I.W., Bolt K., Bou-Orm I.R., Bozorgmehr K., Brady O.J., Brazinova A., Breitborde N.J.K., Brenner H., Britton G., Brugha T.S., Butt Z.A., Cahuana-Hurtado L., Campos-Nonato I.R., Campuzano J.C., Car J., Car M., Cárdenas R., Carrero J.J., Carvalho F., Castañeda-Orjuela C.A., Castillo Rivas J., Catalá-López F., Cercy K., Chalek J., Chang H.-Y., Chang J.-C., Chattopadhyay A., Chaturvedi P., Chiang P.P.-C., Chisumpa V.H., Choi J.-Y.J., Christensen H., Christopher D.J., Chung S.-C., Ciobanu L.G., Cirillo M., Colombara D., Conti S., Cooper C., Cornaby L., Cortesi P.A., Cortinovis M., Costa Pereira A., Cousin E., Criqui M.H., Cromwell E.A., Crowe C.S., Crump J.A., Daba A.K., Dachew B.A., Dadi A.F., Dandona L., Dandona R., Dargan P.I., Daryani A., Daryani M., Das J., Das S.K., Das Neves J., Davis Weaver N., Davletov K., De Courten B., De Leo D., De Neve J.-W., Dellavalle R.P., Demoz G., Deribe K., Des Jarlais D.C., Dey S., Dharmaratne S.D., Dhimal M., Djalalinia S., Doku D.T., Dolan K., Dorsey E.R., Dos Santos K.P.B., Doyle K.E., Driscoll T.R., Dubey M., Dubljanin E., Duncan B.B., Echko M., Edessa D., Edvardsson D., Ehrlich J.R., Eldrenkamp E., El-Khatib Z., Endres M., Endries A.Y., Eshrati B., Eskandarieh S., Esteghamati A., Fakhar M., Farag T., Faramarzi M., Faraon E.J.A., Faro A., Farzadfar F., Fatusi A., Fazeli M.S., Feigin V.L., Feigl A.B., Fentahun N., Fereshtehnejad S.-M., Fernandes E., Fernandes J.C., Fijabi D.O., Filip I., Fischer F., Fitzmaurice C., Flaxman A.D., Flor L.S., Foigt N., Foreman K.J., Frostad J.J., Fürst T., Futran N.D., Gakidou E., Gallus S., Gambashidze K., Gamkrelidze A., Ganji M., Gebre A.K., Gebrehiwot T.T., Gebremedhin A.T., Gelaw Y.A., Geleijnse J.M., Geremew D., Gething P.W., Ghadimi R., Ghasemi Falavarjani K., Ghasemi-Kasman M., Gill P.S., Giref A.Z., Giroud M., Gishu M.D., Giussani G., Godwin W.W., Goli S., Gomez-Dantes H., Gona P.N., Goodridge A., Gopalani S.V., Goryakin Y., Goulart A.C., Grada A., Griswold M., Grosso G., Gugnani H.C., Guo Y., Gupta R., Gupta R., Gupta T., Gupta T., Gupta V., Haagsma J.A., Hachinski V., Hafezi-Nejad N., Hailu G.B., Hamadeh R.R., Hamidi S., Hankey G.J., Harb H.L., Harewood H.C., Harikrishnan S., Haro J.M., Hassen H.Y., Havmoeller R., Hawley C., Hay S.I., He J., Hearps S.J.C., Hegazy M.I., Heibati B., Heidari M., Hendrie D., Henry N.J., Herrera Ballesteros V.H., Herteliu C., Hibstu D.T., Hiluf M.K., Hoek H.W., Homaie Rad E., Horita N., Hosgood H.D., Hosseini M., Hosseini S.R., Hostiuc M., Hostiuc S., Hoy D.G., Hsairi M., Htet A.S., Hu G., Huang J.J., Iburg K.M., Idris F., Igumbor E.U., Ikeda C., Ileanu B.V., Ilesanmi O.S., Innos K., Irvani S.S.N., Irvine C.M.S., Islami F., Jacobs T.A., Jacobsen K.H., Jahanmehr N., Jain R., Jain S.K., Jakovljevic M.M., Jalu M.T., Jamal A.A., Javanbakht M., Jayatilleke A.U., Jeemon P., Jha R.P., Jha V., Józwiak J., John O., Johnson S.C., Jonas J.B., Joshua V., Jürisson M., Kabir Z., Kadel R., Kahsay A., Kalani R., Kar C., Karanikolos M., Karch A., Karema C.K., Karimi S.M., Kasaeian A., Kassa D.H., Kassa G.M., Kassa T.D., Kassebaum N.J., Katikireddi S.V., Kaul A., Kawakami N., Kazanjan K., Kebede S., Keiyoro P.N., Kemp G.R., Kengne A.P., Kereselidze M., Ketema E.B., Khader Y.S., Khafaie M.A., Khajavi A., Khalil I.A., Khan E.A., Khan G., Khan M.N., Khan M.A., Khanal M.N., Khang Y.-H., Khater M.M., Khoja A.T.A., Khosravi A., Khubchandani J., Kibret G.D., Kiirithio D.N., Kim D., Kim Y.J., Kimokoti R.W., Kinfu Y., Kinra S., Kisa A., Kissoon N., Kochhar S., Kokubo Y., Kopec J.A., Kosen S., Koul P.A., Koyanagi A., Kravchenko M., Krishan K., Krohn K.J., Kuate Defo B., Kumar G.A., Kumar P., Kutz M., Kuzin I., Kyu H.H., Lad D.P., Lafranconi A., Lal D.K., Lalloo R., Lam H., Lan Q., Lang J.J., Lansingh V.C., Lansky S., Larsson A., Latifi A., Lazarus J.V., Leasher J.L., Lee P.H., Legesse Y., Leigh J., Leshargie C.T., Leta S., Leung J., Leung R., Levi M., Li Y., Liang J., Liben M.L., Lim L.-L., Lim S.S., Lind M., Linn S., Listl S., Liu P.Y., Liu S., Lodha R., Lopez A.D., Lorch S.A., Lorkowski S., Lotufo P.A., Lucas T.C.D., Lunevicius R., Lurton G., Lyons R.A., Maalouf F., Macarayan E.R.K., Mackay M.T., Maddison E.R., Madotto F., Magdy Abd El Razek H., Magdy Abd El Razek M., Majdan M., Majdzadeh R., Majeed A., Malekzadeh R., Malhotra R., Malta D.C., Mamun A.A., Manguerra H., Manhertz T., Mansournia M.A., Mantovani L.G., Manyazewal T., Mapoma C.C., Margono C., Martinez-Raga J., Martins S.C.O., Martins-Melo F.R., Martopullo I., März W., Massenburg B.B., Mathur M.R., Maulik P.K., Mazidi M., McAlinden C., McGrath J.J., McKee M., Mehata S., Mehrotra R., Mehta K.M., Mehta V., Meier T., Mejia-Rodriguez F., Meles K.G., Melku M., Memiah P., Memish Z.A., Mendoza W., Mengiste D.A., Mengistu D.T., Menota B.G., Mensah G.A., Meretoja A., Meretoja T.J., Mezgebe H.B., Miazgowski T., Micha R., Milam R., Millear A., Miller T.R., Mini G.K., Minnig S., Mirica A., Mirrakhimov E.M., Misganaw A., Mitchell P.B., Mlashu F.W., Moazen B., Mohammad K.A., Mohammadibakhsh R., Mohammed E., Mohammed M.A., Mohammed S., Mokdad A.H., Mola G.L.D., Molokhia M., Momeniha F., Monasta L., Montañez Hernandez J.C., Moosazadeh M., Moradi-Lakeh M., Moraga P., Morawska L., Moreno Velasquez I., Mori R., Morrison S.D., Moses M., Mousavi S.M., Mueller U.O., Murhekar M., Murthy G.V.S., Murthy S., Musa J., Musa K.I., Mustafa G., Muthupandian S., Nagata C., Nagel G., Naghavi M., Naheed A., Naik G.A., Naik N., Najafi F., Naldi L., Nangia V., Nansseu J.R.N., Narayan K.M.V., Nascimento B.R., Negoi I., Negoi R.I., Newton C.R., Ngunjiri J.W., Nguyen G., Nguyen L., Nguyen T.H., Nichols E., Ningrum D.N.A., Nolte E., Nong V.M., Norheim O.F., Norrving B., Noubiap J.J.N., Nyandwi A., Obermeyer C.M., Ofori-Asenso R., Ogbo F.A., Oh I.-H., Oladimeji O., Olagunju A.T., Olagunju T.O., Olivares P.R., De Oliveira P.P.V., Olsen H.E., Olusanya B.O., Olusanya J.O., Ong K., Opio J.N., Oren E., Ortega-Altamirano D.V., Ortiz A., Ozdemir R., Pa M., Pain A.W., Palone M.R.T., Pana A., Panda-Jonas S., Pandian J.D., Park E.-K., Parsian H., Patel T., Pati S., Patil S.T., Patle A., Patton G.C., Paturi V.R., Paudel D., De Moares Pedroso M., Pedroza S.P., Pereira D.M., Perico N., Peterson H., Petzold M., Peykari N., Phillips M.R., Piel F.B., Pigott D.M., Pillay J.D., Piradov M.A., Polinder S., Pond C.D., Postma M.J., Pourmalek F., Prakash S., Prakash V., Prasad N., Prasad N.M., Purcell C., Qorbani M., Quintana H.K., Radfar A., Rafay A., Rafiei A., Rahimi K., Rahimi-Movaghar A., Rahimi-Movaghar V., Rahman M., Rahman M.A., Rahman S.U., Rai R.K., Raju S.B., Ram U., Rana S.M., Rankin Z., Rasella D., Rawaf D.L., Rawaf S., Ray S.E., Razo-García C.A., Reddy P., Reiner R.C., Reis C., Reitsma M.B., Remuzzi G., Renzaho A.M.N., Resnikoff S., Rezaei S., Rezai M.S., Ribeiro A.L., Rios Blancas M.J., Rivera J.A., Roever L., Ronfani L., Roshandel G., Rostami A., Roth G.A., Rothenbacher D., Roy A., Roy N., Ruhago G.M., Sabde Y.D., Sachdev P.S., Sadat N., Safdarian M., Safiri S., Sagar R., Sahebkar A., Sahraian M.A., Sajadi H.S., Salama J., Salamati P., De Freitas Saldanha R., Salimzadeh H., Salomon J.A., Samy A.M., Sanabria J.R., Sancheti P.K., Sanchez-Niño M.D., Santomauro D., Santos I.S., Santric Milicevic M.M., Sarker A.R., Sarrafzadegan N., Sartorius B., Satpathy M., Savic M., Sawhney M., Saxena S., Saylan M.I., Schaeffner E., Schmidhuber J., Schmidt M.I., Schneider I.J.C., Schumacher A.E., Schutte A.E., Schwebel D.C., Schwendicke F., Sekerija M., Sepanlou S.G., Servan-Mori E.E., Shafieesabet A., Shaikh M.A., Shakh-Nazarova M., Shams-Beyranvand M., Sharafi H., Sharif-Alhoseini M., Shariful Islam S.M., Sharma M., Sharma R., She J., Sheikh A., Shfare M.T., Shi P., Shields C., Shigematsu M., Shinohara Y., Shiri R., Shirkoohi R., Shiue I., Shrime M.G., Shukla S.R., Siabani S., Sigfusdottir I.D., Silberberg D.H., Silva D.A.S., Silva J.P., Silveira D.G.A., Singh J.A., Singh L., Singh N.P., Singh V., Sinha D.N., Sinke A.H., Sisay M., Skirbekk V., Sliwa K., Smith A., Soares Filho A.M., Sobaih B.H.A., Somai M., Soneji S., Soofi M., Sorensen R.J.D., Soriano J.B., Soyiri I.N., Sposato L.A., Sreeramareddy C.T., Srinivasan V., Stanaway J.D., Stathopoulou V., Steel N., Stein D.J., Stokes M.A., Sturua L., Sufiyan M.B., Suliankatchi R.A., Sunguya B.F., Sur P.J., Sykes B.L., Sylaja P.N., Szoeke C.E.I., Tabarés-Seisdedos R., Tadakamadla S.K., Tadesse A.H., Taffere G.R., Tandon N., Tariku A.T., Taveira N., Tehrani-Banihashemi A., Temam Shifa G., Temsah M.-H., Terkawi A.S., Tesema A.G., Tesfaye D.J., Tessema B., Thakur J.S., Thomas N., Thompson M.J., Tillmann T., To Q.G., Tobe-Gai R., Tonelli M., Topor-Madry R., Topouzis F., Torre A., Tortajada M., Tran B.X., Tran K.B., Tripathi A., Tripathy S.P., Troeger C., Truelsen T., Tsoi D., Tudor Car L., Tuem K.B., Tyrovolas S., Uchendu U.S., Ukwaja K.N., Ullah I., Updike R., Uthman O.A., Uzochukwu B.S.C., Valdez P.R., Van Boven J.F.M., Varughese S., Vasankari T., Venketasubramanian N., Violante F.S., Vladimirov S.K., Vlassov V.V., Vollset S.E., Vos T., Wagnew F., Waheed Y., Wallin M.T., Walson J.L., Wang Y., Wang Y.-P., Wassie M.M., Weaver M.R., Weiderpass E., Weintraub R.G., Weiss J., Weldegwergs K.G., Werdecker A., West T.E., Westerman R., White R.G., Whiteford H.A., Widecka J., Winkler A.S., Wiysonge C.S., Wolfe C.D.A., Wondimkun Y.A., Workicho A., Wyper G.M.A., Xavier D., Xu G., Yan L.L., Yano Y., Yaseri M., Yimer N.B., Yin P., Yip P., Yirsaw B.D., Yonemoto N., Yonga G., Yoon S.-J., Yotebieng M., Younis M.Z., Yu C., Zadnik V., Zaidi Z., El Sayed Zaki M., Zaman S.B., Zamani M., Zenebe Z.M., Zhou M., Zhu J., Zimsen S.R.M., Zipkin B., Zodpey S., Zuhlke L.J., Murray C.J.L., Lozano R., GBD 2016 Healthcare Access and Quality Collaborators (2018)
      Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries ...
    • A meta-analysis evaluating the role of high-intensity focused ultrasound (HIFU) as a fourth treatment modality for patients with locally advanced pancreatic cancer 

      Fergadi M.P., Magouliotis D.E., Rountas C., Vlychou M., Athanasiou T., Symeonidis D., Pappa P.A., Zacharoulis D. (2022)
      Background: This study aimed to evaluate the outcomes of high-intensity focused ultrasound (HIFU) on patients with advanced pancreatic cancer. Methods: A literature search was performed in PubMed, Scopus and Cochrane ...
    • Meta-analysis of BCOR rearranged sarcomas: challenging the therapeutic approach 

      Kyriazoglou A., Bagos P. (2021)
      Introduction: BCOR rearranged sarcomas comprise a group of malignant mesenchymal tumors that until recently were classified as Ewing sarcomas or as undifferentiated round cell sarcomas. The identification of alterations ...
    • A meta-analysis of liver-first versus classical strategy for synchronous colorectal liver metastases 

      Magouliotis D.E., Tzovaras G., Diamantis A., Tasiopoulou V.S., Zacharoulis D. (2020)
      Background: This study aimed to compare the perioperative outcomes of liver-first (LFS) and classical (CS) strategy for the management of synchronous colorectal liver metastases (sCRLM). Method: A literature search was ...
    • Microvessel Density and Impact of Angiogenesis on Survival of Resected Pancreatic Cancer Patients: A Systematic Review and Meta-analysis 

      Ntellas P., Dadouli K., Perivoliotis K., Sogka E., Pentheroudakis G., Ioannou M., Hadjichristodoulou C., Tepetes K., Mauri D. (2019)
      Objectives Angiogenesis plays a major role in tumor progression and metastasis; however, its role in pancreatic cancer (PC) remains unclear. The aim of the study was to explore the cumulative evidence concerning the impact ...
    • Microvessel Density in Patients with Cutaneous Melanoma: An Up-to-Date Systematic Review and Meta-Analysis 

      Perivoliotis K., Ntellas P., Dadouli K., Koutoukoglou P., Ioannou M., Tepetes K. (2017)
      Background. We conducted a meta-analysis, in order to appraise the effect of microvessel density (MVD) on the survival of patients with cutaneous melanoma. Methods. This study was conducted according to the PRISMA guidelines ...
    • Myeloid-derived suppressor cells in prostate cancer: Present knowledge and future perspectives 

      Koinis F., Xagara A., Chantzara E., Leontopoulou V., Aidarinis C., Kotsakis A. (2022)
      Several lines of research are being investigated to better understand mechanisms implicated in response or resistance to immune checkpoint blockade in prostate cancer (PCa). Myeloid-derived suppressor cells (MDSCs) have ...